SR 26831

• CAT Number: I036604
• CAS Number: 139995-67-8
• Molecular Formula: C19H23ClNO3S+
• Molecular Weight: 380.91
• Purity: 98%
• Synonyms: SR 26831; SR26831; SR-26831
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: [5-[(2-chlorophenyl)methyl]-5-hydroxy-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-ium-2-yl] 2,2-dimethylpropanoate
• InChI: InChI=1S/C19H23ClNO3S/c1-19(2,3)18(22)24-17-10-14-12-21(23,9-8-16(14)25-17)11-13-6-4-5-7-15(13)20/h4-7,10,23H,8-9,11-12H2,1-3H3/q+1
• InChIKey: AZEZNHVYMHQRRH-UHFFFAOYSA-N
• SMILES: CC(C)(C)C(=O)OC1=CC2=C(S1)CC[N+](C2)(CC3=CC=CC=C3Cl)O

SR 26831（Cat No.:I036604）is an experimental compound primarily studied for its potential therapeutic effects on central nervous system (CNS) disorders. It is a selective antagonist of the 5-HT3 receptor, which plays a role in neurotransmission and is involved in processes such as nausea, vomiting, and anxiety. By blocking this receptor, SR 26831 may have therapeutic applications in conditions like anxiety disorders, irritable bowel syndrome, and nausea caused by chemotherapy. While preclinical studies show promise, further clinical trials are necessary to assess its safety, efficacy, and potential use in treating various disorders.